Top 5 Most-Read Articles From the Center of Health Equity and Access 2023
December 25th 2023The top articles of 2023 addressed key issues such as representation gaps in aRCC research, concerns about the 340B program's impact on asthma disparities, slow adoption of equity innovations, potential biases in type 2 diabetes risk models, and addressing disparities in psoriasis treatment based on race and culture.
Read More
Patients With Breast Cancer, HIV More Likely to Experience Suboptimal Adjuvant Chemotherapy Delivery
December 25th 2023The researchers noted the need for strategies to better support women living with HIV with breast cancer during toxic therapies to improve outcomes among this growing population.
Read More
Top 5 Most-Read Breast Cancer Articles of 2023
December 24th 2023In breast cancer coverage this year, topline results from the phase 3 NATALEE trial made waves in March, with our other most-read content in the space covering an expanded indication for abemaciclib, revised screening recommendations, a new potential treatment to reduce radiation exposure, and the benefits of diet and exercise on patient outcomes.
Read More
Most PCPs Unfamiliar With Biologic Therapy for Patients With Severe Asthma
December 24th 2023Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.
Read More
Top 5 Most-Read Oncology Articles of 2023
December 22nd 2023Our most-read oncology content of 2023 included meeting coverage, research on an algorithm using patient-reported outcomes to predict hospital visits, and the launch of an National Comprehensive Cancer Network pilot project aiming to measure health equity.
Read More
alloHSCT Yields Benefits in R/R AML Regardless of Leukemia Burden
December 22nd 2023Those with chronic graft-versus-host-disease who have received allogeneic hematopoietic stem cell transplant (alloHSCT) may experience enhanced graft-versus-leukemia effects, thus producing a lower relapse rate in acute myeloid leukemia.
Read More
Health Plan Design: Employers as the Architects of Health Equity
December 22nd 2023Employers, recognized as pivotal contributors to health equity, are urged to prioritize equitable benefits, address the complexity of health plans, and engage in education, data-driven interventions, and systematic measurements to comprehensively improve outcomes for diverse employee populations.
Read More
Understanding Misdiagnoses in MS: Copycat Conditions, Testing Barriers, and More
December 22nd 2023Misdiagnoses of multiple sclerosis (MS) represent one of the prominent challenges in MS for patients, clinicians, and researchers. A variety of factors influence misdiagnosis, including testing deficiencies, copycat diseases, and more.
Read More
What We’re Reading: Health Data Breaches; Medicaid Grassroots Groups; PCP Shortage Impact
December 22nd 2023As many as 116 million patients were impacted by large health data breaches this year; grassroots groups have begun leading the push to re-enroll patients denied Medicare coverage for bureaucratic reasons; a nationwide shortage of primary care clinicians is causing more distrust in the health care system.
Read More
Community and Connection Drive UPMC Health Plan’s Multifaceted Success
December 22nd 2023In September, The American Journal of Managed Care® joined 4 individuals whose involvement with UPMC Health Plan, a Strategic Alliance Partner of AJMC®, has proved to be instrumental in furthering health equity and providing high-quality care in Pennsylvania, Ohio, West Virginia, and Maryland.
Read More
Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast Cancer
December 22nd 2023A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer.
Read More
NAHCP’s Mike Thompson Highlights Crucial Strategies for Enhancing Employee Health and Equity
December 22nd 2023At this year’s Community Oncology Alliance Payer Exchange Summit on Oncology Payment Reform, leaders from across all facets of the cancer care space engaged in thought-provoking panel discussions and debates. They have a common aim: to optimize cancer care delivery and ensure patients have a positive experience throughout their cancer care journey.
Read More
Non-Inflammatory Factors May Affect Disease Measurement and Treatment Targets in RA, Study Finds
December 21st 2023An observational registry study revealed that inflammatory disease activity is not the only factor influencing the achievement of treatment targets for patients with rheumatoid arthritis (RA).
Read More
More than 15.3 million Americans enrolled in health insurance under the Affordable Care Act for 2024, which is a 33% increase from last year; emergency contraception sales in the United States may spike by around 10% in the new year; top Biden administration officials met with prominent civil rights and public health leaders on Tuesday amid the decision to delay the menthol cigarette ban.
Read More